Targeting STAT6 to mitigate sepsis-induced muscle atrophy and weakness: Modulation of mitochondrial dysfunction, ferroptosis, and CHI3L1-Mediated satellite cell loss
Open Access
- 16 December 2023
- journal article
- research article
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 37, 101608
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (8196020219)
- Natural Science Foundation of Jiangxi Province (20202BAB206058, 20212BAB206043)
This publication has 44 references indexed in Scilit:
- Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis—Experience from two prospective cohortsImmunobiology, 2013
- Satellite Cells and the Muscle Stem Cell NichePhysiological Reviews, 2013
- The aged niche disrupts muscle stem cell quiescenceNature, 2012
- Transcriptional regulation by STAT6Immunologic Research, 2011
- A Novel STAT6 Inhibitor AS1517499 Ameliorates Antigen-Induced Bronchial Hypercontractility in MiceAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- YKL-40 IDENTIFIED BY PROTEOMIC ANALYSIS AS A BIOMARKER OF SEPSISShock, 2009
- Dysregulation of Mitochondrial Dynamics and the Muscle Transcriptome in ICU Patients Suffering from Sepsis Induced Multiple Organ FailurePLOS ONE, 2008
- Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammationCell Metabolism, 2006
- Animal Models of sepsis: setting the stageNature Reviews Drug Discovery, 2005
- IL-4–induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsisSurgery, 2000